Physician profile
Torben Svendsen
NPI 1700165081
$1,187.89
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.53 · 2020: $45.34 · 2021: $164 · 2022: $292 · 2023: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $197.77 | 2020-2023 | Mounjaro, Trulicity, Emgality |
| Otsuka America Pharmaceutical, INC. | $193.91 | 2021-2023 | Rexulti |
| Abbvie INC. | $179.01 | 2022-2023 | Vraylar, Ubrelvy |
| Novo Nordisk INC | $173.93 | 2021-2023 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $119.09 | 2021-2023 | Shingrix, Arexvy |
| Amgen INC. | $57.11 | 2022 | |
| Esperion Therapeutics, INC. | $54.49 | 2021 | |
| Xeris Pharmaceuticals, INC. | $54.37 | 2023 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $32.96 | 2022-2023 | |
| Lundbeck LLC | $27.81 | 2023 | Vyepti |
| Janssen Pharmaceuticals, INC | $26.44 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $23.99 | 2023 | |
| Paratek Pharmaceuticals, INC. | $19.31 | 2023 | Nuzyra |
| Pfizer INC. | $16.17 | 2021 | |
| Mannkind Corporation | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torben Svendsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.